Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.

Crawford J, Nygard K, Gan BS, O'Gorman DB.

Exp Dermatol. 2015 Feb;24(2):120-6. doi: 10.1111/exd.12601.

PMID:
25421393
2.

IGF2 expression and β-catenin levels are increased in Frozen Shoulder Syndrome.

Raykha CN, Crawford JD, Burry AF, Drosdowech DS, Faber KJ, Gan BS, O'Gorman DB.

Clin Invest Med. 2014 Aug 1;37(4):E262-7.

PMID:
25090267
3.

Monitoring collagen synthesis in fibroblasts using fluorescently labeled tRNA pairs.

Liu J, Pampillo M, Guo F, Liu S, Cooperman BS, Farrell I, Dahary D, Gan BS, O'Gorman DB, Smilansky Z, Babwah AV, Leask A.

J Cell Physiol. 2014 Sep;229(9):1121-9. doi: 10.1002/jcp.24630.

PMID:
24676899
4.

Operative trends and physician treatment costs associated with Dupuytren's disease in Canada.

Liu W, O'Gorman DB, Gan BS.

Can J Plast Surg. 2013 Winter;21(4):229-33.

5.

IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.

Raykha C, Crawford J, Gan BS, Fu P, Bach LA, O'Gorman DB.

Biochim Biophys Acta. 2013 Oct;1832(10):1511-9. doi: 10.1016/j.bbadis.2013.04.018. Epub 2013 Apr 24.

6.

Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.

Satish L, O'Gorman DB, Johnson S, Raykha C, Gan BS, Wang JH, Kathju S.

Cell Stress Chaperones. 2013 Jul;18(4):397-404. doi: 10.1007/s12192-012-0392-9. Epub 2013 Jan 6.

7.

Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.

Satish L, LaFramboise WA, Johnson S, Vi L, Njarlangattil A, Raykha C, Krill-Burger JM, Gallo PH, O'Gorman DB, Gan BS, Baratz ME, Ehrlich GD, Kathju S.

BMC Med Genomics. 2012 May 4;5:15. doi: 10.1186/1755-8794-5-15.

8.

Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Ng WK, Rosenblatt Y, Brock GB, O'Gorman DB, Siang Gan B.

Can J Plast Surg. 2010 Spring;18(1):e5-9.

9.

Genipin-Cross-linked Electrospun Collagen Fibers.

Mekhail M, Wong KK, Padavan DT, Wu Y, O'Gorman DB, Wan W.

J Biomater Sci Polym Ed. 2010 Nov 17. [Epub ahead of print]

PMID:
21083975
10.

Molecular mechanisms and treatment strategies for Dupuytren's disease.

O'Gorman DB, Vi L, Gan BS.

Ther Clin Risk Manag. 2010 Sep 7;6:383-90.

11.

The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence.

Vi L, Gan BS, O'Gorman DB.

Med Hypotheses. 2010 Mar;74(3):510-2. doi: 10.1016/j.mehy.2009.10.009. Epub 2009 Nov 5.

PMID:
19896280
12.

Protein biomarker analysis of primary Peyronie's disease cells.

De Young LX, Bella AJ, O'Gorman DB, Gan BS, Lim KB, Brock GB.

J Sex Med. 2010 Jan;7(1 Pt 1):99-106. doi: 10.1111/j.1743-6109.2009.01556.x. Epub 2009 Nov 3.

PMID:
19889147
13.

Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.

Vi L, Feng L, Zhu RD, Wu Y, Satish L, Gan BS, O'Gorman DB.

Exp Cell Res. 2009 Dec 10;315(20):3574-86. doi: 10.1016/j.yexcr.2009.07.015. Epub 2009 Jul 18.

PMID:
19619531
14.

Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Vi L, Njarlangattil A, Wu Y, Gan BS, O'Gorman DB.

BMC Musculoskelet Disord. 2009 Jun 19;10:72. doi: 10.1186/1471-2474-10-72.

15.

Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis.

Bhavsar S, Nimigan A, Hackam DG, O'Gorman DB, Gan BS, Spence JD.

Clin Invest Med. 2009 Apr 1;32(2):E95-102.

PMID:
19331810
16.

An alternative kinase activity assay for primary cultures derived from clinical isolates.

McLean K, Wu Y, Gan BS, O'Gorman DB.

Clin Invest Med. 2009 Apr 1;32(2):E84-94.

PMID:
19331809
17.

Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture.

Satish L, LaFramboise WA, O'Gorman DB, Johnson S, Janto B, Gan BS, Baratz ME, Hu FZ, Post JC, Ehrlich GD, Kathju S.

BMC Med Genomics. 2008 Apr 23;1:10. doi: 10.1186/1755-8794-1-10.

18.

Is there a role for proteomics in Peyronie's disease?

Domes T, De Young L, O'Gorman DB, Gan BS, Bella AJ, Brock G.

J Sex Med. 2007 Jul;4(4 Pt 1):867-77. Epub 2007 Apr 6. Review.

PMID:
17419813
19.

Beta-catenin signaling in fibroproliferative disease.

Bowley E, O'Gorman DB, Gan BS.

J Surg Res. 2007 Mar;138(1):141-50. Epub 2006 Nov 15. Review.

PMID:
17109886
20.

Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.

O'Gorman DB, Wu Y, Seney S, Zhu RD, Gan BS.

J Negat Results Biomed. 2006 Aug 30;5:13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk